{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:46:59Z","timestamp":1773470819127,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005942","name":"Butantan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bjid.2024.103856","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:56:13Z","timestamp":1722887773000},"page":"103856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-9672","authenticated-orcid":false,"given":"Expedito J.A.","family":"Luna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 C.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela A.","family":"Roediger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erique J.F.P.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia E.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o I.D.","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro H.M.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Alves","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5152-0984","authenticated-orcid":false,"given":"Lucas","family":"Ragiotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana N.C.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2024.103856_bib0001","series-title":"COVID-19 Vaccine Tracker and Landscape","year":"2023"},{"key":"10.1016\/j.bjid.2024.103856_bib0002","doi-asserted-by":"crossref","unstructured":"Pal\u00e1cios R, Batista AP, Albuquerque CSN, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. Preprint SSRN. https:\/\/doi.org\/10.2139\/ssrn.3822780, [accessed April 14, 2021].","DOI":"10.2139\/ssrn.3822780"},{"key":"10.1016\/j.bjid.2024.103856_bib0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (Coronavac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2024.103856_bib0004","series-title":"Brasil\/Minist\u00e9rio Da Sa\u00fade. Coronavirus, COVID-19, Guia de Vigil\u00e2ncia Epidemiol\u00f3gica","first-page":"22","year":"2022"},{"key":"10.1016\/j.bjid.2024.103856_bib0005","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"WHO working group on the clinical characterisation and management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2024.103856_bib0006","article-title":"Instituto Brasileiro de Geografia e Estat\u00edstica \u2013 IBGE. Estimativa populacional","year":"2021","journal-title":"Cidades e Estados"},{"key":"10.1016\/j.bjid.2024.103856_bib0007","doi-asserted-by":"crossref","first-page":"n2015","DOI":"10.1136\/bmj.n2015","article-title":"Effectiveness of the Coronavac vaccine in older adults during a gamma variant associated epidemic of COVID-19 in Brazil: test negative case-control study","volume":"371","author":"Ranzani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bjid.2024.103856_bib0008","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","article-title":"Vaccine effectiveness of one, two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population based observational study","volume":"22","author":"McMenamin","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2024.103856_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M21-3509","article-title":"Effectiveness of inactivated COVID-19 vaccines against illness caused by the B.1.617.2 (Delta) variant during an outbreak in Guangdong, China","volume":"175","author":"Kang","year":"2022","journal-title":"Ann Int Med"},{"key":"10.1016\/j.bjid.2024.103856_bib0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2024.103856_bib0011","article-title":"The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study","volume":"20","author":"Santos","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.bjid.2024.103856_bib0012","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.vaccine.2021.09.052","article-title":"A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18\u201359 years: an interim analysis in Indonesia","volume":"39","author":"Fadlyana","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2024.103856_bib0013","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(22)00089-7","article-title":"Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden","volume":"399","author":"Nordstrom","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bjid.2024.103856_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54777","article-title":"Estimation of vaccine effectiveness of Coronavac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 Omicron","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bjid.2024.103856_bib0015","unstructured":"FIOCRUZ. SARS-CoV-2 Genomic Surveillance in Brazil. https:\/\/www.genomahcov.fiocruz.br, 2023 [accessed 22 March 2023]."}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T02:28:48Z","timestamp":1729823328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867024001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1413867024001399"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103856","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103856"}}